- Laureate To Add Single-Use Bioreactor (S.U.B.) To Its Portfolio Of Assets
-
PRINCETON, N.J., Sept. 18 /PRNewswire/ -- Laureate Pharma, Inc., a
full-service biopharmaceutical development and protein production company,
today announced that it is increasing its existing manufacturing capacity
by adding two Single-Use Bioreactors (S.U.B.). Acquisition of a 250L and a
1000L S.U.B. will give Laureate greater flexibility in meeting the varying
needs of its clients.
(Logo: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO )
The S.U.B. is a single-use alternative to conventional stirred tank
bioreactors. The S.U.B. consists of a permanent stainless steel outer
support container and a S.U.B. Bioprocess Container (BPC(R)), integrated
with an existing bioreactor control system. This makes the S.U.B. a
flexible, rapid and economic option to update or increase the bioreactor
capacity. The S.U.B. will supplement Laureate's current single-use
bioreactors -- Wave Bioreactors(R) and hollow-fiber systems -- as well as
the conventional stainless steel stirred-tank bioreactors.
"We are excited about adding the S.U.B. to increase our bioreactor
capacity. It is a scalable technology that will support the demand from our
growing client base and meet their needs and manufacturing objectives,"
said Robert J. Broeze, Ph. D., President & Chief Executive Officer of
Laureate. "The HyClone S.U.B. provides us with all the advantages of
single-use bioprocessing, while maintaining aspect ratios and agitation
mechanisms comparable to traditional stainless steel stirred-tank
bioreactors."
About Laureate Pharma, Inc.
Laureate Pharma is a full-service biopharmaceutical development and
protein production company located in Princeton, New Jersey. Laureate
Pharma offers superior bioprocessing services that accelerate new products
from development through production. Laureate provides a wide range of
specialized services from process design and development to full-scale cGMP
production, purification, aseptic filling, testing, validation, analytical
services, and regulatory support. Laureate is focused on two active
segments of the biopharmaceutical industry: monoclonal antibodies and
recombinant protein products. For more information, contact Michael
Cavanaugh, Vice President Sales, Marketing, and Business Development at
(609) 919-3400, or info@laureatepharma.com or visit http://www.laureatepharma.com.
SOURCE Laureate Pharma, Inc.
 back to top
Related links:
http://www.laureatepharma.com/
Photo Notes:
NewsCom: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
CONTACT:
Michael Cavanaugh, Vice President of Sales,
Marketing, and Business Development, Laureate Pharma, Inc.,
+1-609-919-3400, info@laureatepharma.com
|
